Suchergebnisse - "CIRCULATING tumor DNA"

Brave New World: Analysis of Early Clinical Experience With Molecular Sequencing in the Treatment of Rectal Cancer.

Autoren: Yee JT Eltahir AA Oduyale OK et al.

Quelle: Diseases of the colon and rectum [Dis Colon Rectum] 2025 Dec 01; Vol. 68 (12), pp. 1414-1421. Date of Electronic Publication: 2025 Aug 26.

Publikationsart: Journal Article; Video-Audio Media

Info zur Zeitschrift: Publisher: Lippincott Country of Publication: United States NLM ID: 0372764 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1530-0358 (Electronic) Linking ISSN: 00123706 NLM ISO Abbreviation: Dis Colon Rectum Subsets: MEDLINE

MeSH-Schlagworte: Rectal Neoplasms*/genetics , Rectal Neoplasms*/therapy , Rectal Neoplasms*/pathology , High-Throughput Nucleotide Sequencing*/methods , High-Throughput Nucleotide Sequencing*/statistics & numerical data , Circulating Tumor DNA*/genetics , Circulating Tumor DNA*/blood , Genetic Testing*/methods , Genetic Testing*/statistics & numerical data, Humans ; Female ; Male ; Retrospective Studies ; Middle Aged ; Aged ; Neoadjuvant Therapy/methods ; Neoplasm Recurrence, Local/genetics ; Mutation ; Biomarkers, Tumor/genetics ; Adult

Ultrasensitive single-particle collision electrochemical platform employing CRISPR/Cas12a for ctDNA biosensing.

Autoren: Shi S Qin F Wu J et al.

Quelle: Analytica chimica acta [Anal Chim Acta] 2025 Nov 22; Vol. 1376, pp. 344590. Date of Electronic Publication: 2025 Sep 02.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 0370534 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-4324 (Electronic) Linking ISSN: 00032670 NLM ISO Abbreviation: Anal Chim Acta Subsets: MEDLINE

MeSH-Schlagworte: Biosensing Techniques*/methods , Circulating Tumor DNA*/blood , Circulating Tumor DNA*/analysis , Circulating Tumor DNA*/genetics , Electrochemical Techniques*/methods , CRISPR-Cas Systems*, Humans ; Silver/chemistry ; Metal Nanoparticles/chemistry ; Limit of Detection

The promise of ctDNA-based, molecularly-driven early switch therapy from PADA-1 to SERENA-6.

Autoren: Oliveira LJC Mano MS Barrios C et al.

Quelle: Breast cancer research and treatment [Breast Cancer Res Treat] 2025 Nov 21; Vol. 215 (1), pp. 5. Date of Electronic Publication: 2025 Nov 21.

Publikationsart: Journal Article; Review

Info zur Zeitschrift: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

MeSH-Schlagworte: Circulating Tumor DNA*/genetics , Circulating Tumor DNA*/blood , Breast Neoplasms*/drug therapy , Breast Neoplasms*/genetics , Breast Neoplasms*/blood , Breast Neoplasms*/pathology , Breast Neoplasms*/diagnosis , Biomarkers, Tumor*/genetics , Biomarkers, Tumor*/blood, Humans ; Female ; Estrogen Receptor alpha/genetics ; Liquid Biopsy ; Mutation ; Antineoplastic Agents, Hormonal/therapeutic use ; Receptor, ErbB-2/metabolism

Circulating Tumor DNA as a Biomarker for Precision Medicine in Prostate Cancer: A Systematic Review.

Autoren: Chanhih N Laraqui A Hassine S et al.

Quelle: International journal of molecular sciences [Int J Mol Sci] 2025 Nov 15; Vol. 26 (22). Date of Electronic Publication: 2025 Nov 15.

Publikationsart: Journal Article; Systematic Review

Info zur Zeitschrift: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

MeSH-Schlagworte: Biomarkers, Tumor*/blood , Biomarkers, Tumor*/genetics , Circulating Tumor DNA*/blood , Circulating Tumor DNA*/genetics , Precision Medicine*/methods , Prostatic Neoplasms*/genetics , Prostatic Neoplasms*/blood , Prostatic Neoplasms*/drug therapy , Prostatic Neoplasms*/diagnosis, Humans ; Male ; Mutation

Current status and perspective of ctDNA-based MRD testing in breast cancer: a systematic review.

Autoren: Ozaki Y Iwata H

Quelle: Japanese journal of clinical oncology [Jpn J Clin Oncol] 2025 Nov 08; Vol. 55 (11), pp. 1210-1216.

Publikationsart: Journal Article; Systematic Review; Review

Info zur Zeitschrift: Publisher: Oxford University Press Country of Publication: England NLM ID: 0313225 Publication Model: Print Cited Medium: Internet ISSN: 1465-3621 (Electronic) Linking ISSN: 03682811 NLM ISO Abbreviation: Jpn J Clin Oncol Subsets: MEDLINE

MeSH-Schlagworte: Breast Neoplasms*/genetics , Breast Neoplasms*/blood , Breast Neoplasms*/pathology , Breast Neoplasms*/therapy , Circulating Tumor DNA*/blood , Circulating Tumor DNA*/genetics , Neoplasm, Residual*/diagnosis , Neoplasm Recurrence, Local*/genetics , Neoplasm Recurrence, Local*/blood , Biomarkers, Tumor*/blood, Humans ; Female

Clearance of TP53 Mutations in ctDNA Reflects Therapeutic Response in Advanced Pancreatic Cancer Patients.

Autoren: Cheon YK Lee SH Kim DW et al.

Quelle: Anticancer research [Anticancer Res] 2025 Nov; Vol. 45 (11), pp. 4891-4907.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8102988 Publication Model: Print Cited Medium: Internet ISSN: 1791-7530 (Electronic) Linking ISSN: 02507005 NLM ISO Abbreviation: Anticancer Res Subsets: MEDLINE

MeSH-Schlagworte: Pancreatic Neoplasms*/genetics , Pancreatic Neoplasms*/drug therapy , Pancreatic Neoplasms*/pathology , Pancreatic Neoplasms*/blood , Circulating Tumor DNA*/genetics , Circulating Tumor DNA*/blood , Tumor Suppressor Protein p53*/genetics , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Mutation* , Carcinoma, Pancreatic Ductal*/genetics , Carcinoma, Pancreatic Ductal*/drug therapy , Carcinoma, Pancreatic Ductal*/blood , Carcinoma, Pancreatic Ductal*/pathology , Biomarkers, Tumor*/genetics, Humans ; Male ; Middle Aged ; Female ; Aged ; Deoxycytidine/analogs & derivatives ; Deoxycytidine/administration & dosage ; Deoxycytidine/therapeutic use ; Gemcitabine ; Fluorouracil/therapeutic use ; Fluorouracil/administration & dosage ; Leucovorin/therapeutic use ; Leucovorin/administration & dosage ; Irinotecan/therapeutic use ; Irinotecan/administration & dosage ; Oxaliplatin/therapeutic use ; Oxaliplatin/administration & dosage ; Paclitaxel/administration & dosage ; Paclitaxel/therapeutic use ; High-Throughput Nucleotide Sequencing ; Treatment Outcome ; Adult ; Albumins/administration & dosage

Prognostic significance of early on-treatment evolution of circulating tumor DNA in advanced ER-positive/HER2-negative breast cancer.

Autoren: Mamann A Pradat Y Bidard FC et al.

Quelle: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2025 Nov; Vol. 36 (11), pp. 1342-1355. Date of Electronic Publication: 2025 Jul 05.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

MeSH-Schlagworte: Circulating Tumor DNA*/blood , Circulating Tumor DNA*/genetics , Breast Neoplasms*/drug therapy , Breast Neoplasms*/genetics , Breast Neoplasms*/blood , Breast Neoplasms*/pathology , Breast Neoplasms*/mortality , Biomarkers, Tumor*/blood , Biomarkers, Tumor*/genetics , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use, Humans ; Female ; Receptor, ErbB-2/metabolism ; Receptors, Estrogen/metabolism ; Prognosis ; Middle Aged ; Adult ; Aged ; Progression-Free Survival

Circulating tumor DNA and urinary tumor DNA: useful biomarkers for bladder cancer detection.

Autoren: Lin N Zhou Y Li Y et al.

Quelle: Expert review of molecular diagnostics [Expert Rev Mol Diagn] 2025 Nov; Vol. 25 (11), pp. 817-828. Date of Electronic Publication: 2025 Sep 24.

Publikationsart: Journal Article; Review

Info zur Zeitschrift: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101120777 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8352 (Electronic) Linking ISSN: 14737159 NLM ISO Abbreviation: Expert Rev Mol Diagn Subsets: MEDLINE

MeSH-Schlagworte: Urinary Bladder Neoplasms*/diagnosis , Urinary Bladder Neoplasms*/urine , Urinary Bladder Neoplasms*/genetics , Urinary Bladder Neoplasms*/blood , Biomarkers, Tumor*/urine , Circulating Tumor DNA*/urine , Circulating Tumor DNA*/genetics, Humans ; Liquid Biopsy/methods ; Prognosis ; Early Detection of Cancer/methods

Treatment-agnostic joint modeling of longitudinal circulating tumor dna predicts survival across first-line regimens in metastatic non-squamous NSCLC.

Autoren: Yuan M Lin X Ding H et al.

Quelle: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences [Eur J Pharm Sci] 2025 Nov 01; Vol. 214, pp. 107275. Date of Electronic Publication: 2025 Sep 15.

Publikationsart: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial

Info zur Zeitschrift: Publisher: Elsevier Science B.V Country of Publication: Netherlands NLM ID: 9317982 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0720 (Electronic) Linking ISSN: 09280987 NLM ISO Abbreviation: Eur J Pharm Sci Subsets: MEDLINE

MeSH-Schlagworte: Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/blood , Carcinoma, Non-Small-Cell Lung*/genetics , Carcinoma, Non-Small-Cell Lung*/mortality , Circulating Tumor DNA*/blood , Circulating Tumor DNA*/genetics , Lung Neoplasms*/drug therapy , Lung Neoplasms*/blood , Lung Neoplasms*/genetics , Lung Neoplasms*/mortality , Lung Neoplasms*/pathology, Aged ; Female ; Humans ; Male ; Middle Aged

Circulating tumor DNA in early-stage triple-negative breast cancer: clinical landscape and key open challenges.

Autoren: De Placido P Parsons HA

Quelle: Current opinion in oncology [Curr Opin Oncol] 2025 Nov 01; Vol. 37 (6), pp. 534-545. Date of Electronic Publication: 2025 Jul 16.

Publikationsart: Journal Article; Review

Info zur Zeitschrift: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9007265 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1531-703X (Electronic) Linking ISSN: 10408746 NLM ISO Abbreviation: Curr Opin Oncol Subsets: MEDLINE

MeSH-Schlagworte: Circulating Tumor DNA*/blood , Circulating Tumor DNA*/genetics , Triple Negative Breast Neoplasms*/blood , Triple Negative Breast Neoplasms*/genetics , Triple Negative Breast Neoplasms*/pathology , Triple Negative Breast Neoplasms*/therapy , Triple Negative Breast Neoplasms*/diagnosis , Biomarkers, Tumor*/blood , Biomarkers, Tumor*/genetics, Humans ; Female ; Neoplasm Staging ; Neoplasm, Residual ; Neoplasm Recurrence, Local/blood

The genomic and epigenomic abnormalities of plasma cfDNA as liquid biopsy biomarkers to detect hepatocellular carcinoma: a multicenter cohort study.

Autoren: Guo D Huang A Sun J et al.

Quelle: Journal of hematology & oncology [J Hematol Oncol] 2025 Oct 29; Vol. 18 (1), pp. 94. Date of Electronic Publication: 2025 Oct 29.

Publikationsart: Journal Article; Multicenter Study; Letter

Info zur Zeitschrift: Publisher: Biomed Central Country of Publication: England NLM ID: 101468937 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-8722 (Electronic) Linking ISSN: 17568722 NLM ISO Abbreviation: J Hematol Oncol Subsets: MEDLINE

MeSH-Schlagworte: Carcinoma, Hepatocellular*/genetics , Carcinoma, Hepatocellular*/diagnosis , Carcinoma, Hepatocellular*/blood , Liver Neoplasms*/genetics , Liver Neoplasms*/diagnosis , Liver Neoplasms*/blood , Biomarkers, Tumor*/genetics , Biomarkers, Tumor*/blood , Circulating Tumor DNA*/blood , Circulating Tumor DNA*/genetics, Humans ; Male ; Female ; Middle Aged ; Liquid Biopsy/methods ; DNA Methylation ; Aged ; Cohort Studies ; Mutation ; Adult ; Epigenomics ; Genomics ; High-Throughput Nucleotide Sequencing ; Early Detection of Cancer

Linear Ligand-Regulated Coordination Aggregation-Induced Electrochemiluminescence for Circulating Tumor DNA Measurement Combined with a Cruciform Tripedal DNA Walker Output Strategy.

Autoren: Hu Y Wang Z Chen YF et al.

Quelle: ACS sensors [ACS Sens] 2025 Oct 24; Vol. 10 (10), pp. 7832-7841. Date of Electronic Publication: 2025 Oct 09.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: American Chemical Society Country of Publication: United States NLM ID: 101669031 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2379-3694 (Electronic) Linking ISSN: 23793694 NLM ISO Abbreviation: ACS Sens Subsets: MEDLINE

MeSH-Schlagworte: Electrochemical Techniques*/methods , Luminescent Measurements*/methods , Biosensing Techniques*/methods , Circulating Tumor DNA*/analysis , Circulating Tumor DNA*/blood , Coordination Complexes*/chemistry , Coordination Complexes*/chemical synthesis , DNA*/chemistry, Humans ; Ligands ; Zinc/chemistry ; Limit of Detection

ctDNA in Pancreatic Adenocarcinoma: A Critical Appraisal.

Autoren: Ojha S Sessions W Zhou Y et al.

Quelle: Current oncology (Toronto, Ont.) [Curr Oncol] 2025 Oct 22; Vol. 32 (11). Date of Electronic Publication: 2025 Oct 22.

Publikationsart: Journal Article; Review

Info zur Zeitschrift: Publisher: MDPI Country of Publication: Switzerland NLM ID: 9502503 Publication Model: Electronic Cited Medium: Internet ISSN: 1718-7729 (Electronic) Linking ISSN: 11980052 NLM ISO Abbreviation: Curr Oncol Subsets: MEDLINE

MeSH-Schlagworte: Circulating Tumor DNA*/blood , Circulating Tumor DNA*/genetics , Pancreatic Neoplasms*/genetics , Pancreatic Neoplasms*/blood , Pancreatic Neoplasms*/diagnosis , Pancreatic Neoplasms*/pathology , Biomarkers, Tumor*/blood , Biomarkers, Tumor*/genetics , Carcinoma, Pancreatic Ductal*/genetics , Carcinoma, Pancreatic Ductal*/blood , Adenocarcinoma*/genetics , Adenocarcinoma*/blood, Humans ; Prognosis

Dynamic Monitoring of Recurrent Ovarian Cancer Using Serial ctDNA: A Real-World Case Series.

Autoren: Rios-Doria E Reichel JB Radke MR et al.

Quelle: Current oncology (Toronto, Ont.) [Curr Oncol] 2025 Oct 21; Vol. 32 (10). Date of Electronic Publication: 2025 Oct 21.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: MDPI Country of Publication: Switzerland NLM ID: 9502503 Publication Model: Electronic Cited Medium: Internet ISSN: 1718-7729 (Electronic) Linking ISSN: 11980052 NLM ISO Abbreviation: Curr Oncol Subsets: MEDLINE

MeSH-Schlagworte: Ovarian Neoplasms*/genetics , Ovarian Neoplasms*/blood , Ovarian Neoplasms*/pathology , Circulating Tumor DNA*/blood , Circulating Tumor DNA*/genetics , Neoplasm Recurrence, Local*/blood , Neoplasm Recurrence, Local*/genetics , Biomarkers, Tumor*/blood , Biomarkers, Tumor*/genetics, Humans ; Female ; Middle Aged ; Aged ; Adult ; CA-125 Antigen/blood

Clinical implications of ctDNA-based minimal residual disease detection in newly diagnosed peripheral T-cell lymphoma: a single-center cohort study.

Autoren: Liang JH Hua W Yin H et al.

Quelle: Cell communication and signaling : CCS [Cell Commun Signal] 2025 Oct 15; Vol. 23 (1), pp. 441. Date of Electronic Publication: 2025 Oct 15.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: BioMed Central Country of Publication: England NLM ID: 101170464 Publication Model: Electronic Cited Medium: Internet ISSN: 1478-811X (Electronic) Linking ISSN: 1478811X NLM ISO Abbreviation: Cell Commun Signal Subsets: MEDLINE

MeSH-Schlagworte: Lymphoma, T-Cell, Peripheral*/genetics , Lymphoma, T-Cell, Peripheral*/diagnosis , Lymphoma, T-Cell, Peripheral*/blood , Lymphoma, T-Cell, Peripheral*/pathology , Circulating Tumor DNA*/blood , Circulating Tumor DNA*/genetics , Neoplasm, Residual*/diagnosis , Neoplasm, Residual*/genetics, Humans ; Female ; Male ; Middle Aged ; Aged ; Adult ; Cohort Studies ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/blood ; Dioxygenases ; Prognosis ; DNA-Binding Proteins

Correlation between circulating tumor DNA quantity assessed by methylated markers and tumor volume in patients with metastatic pancreatic adenocarcinoma.

Autoren: Caliez O Wagner M Taly V et al.

Quelle: Scientific reports [Sci Rep] 2025 Oct 07; Vol. 15 (1), pp. 34865. Date of Electronic Publication: 2025 Oct 07.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

MeSH-Schlagworte: Circulating Tumor DNA*/blood , Circulating Tumor DNA*/genetics , Pancreatic Neoplasms*/pathology , Pancreatic Neoplasms*/genetics , Pancreatic Neoplasms*/blood , Biomarkers, Tumor*/genetics , Biomarkers, Tumor*/blood , DNA Methylation* , Carcinoma, Pancreatic Ductal*/genetics , Carcinoma, Pancreatic Ductal*/pathology , Carcinoma, Pancreatic Ductal*/blood, Humans ; Female ; Male ; Middle Aged ; Aged ; Tumor Burden ; Neoplasm Metastasis ; Homeodomain Proteins/genetics ; Adult ; Prognosis

Co-detection of mutations and methylations in cerebrospinal fluid ctdna for minimally-invasive diagnosis of brainstem glioma.

Autoren: Li T Wang H Wang Y et al.

Quelle: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2025 Oct 07; Vol. 44 (1), pp. 283. Date of Electronic Publication: 2025 Oct 07.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: BioMed Central Country of Publication: England NLM ID: 8308647 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-9966 (Electronic) Linking ISSN: 03929078 NLM ISO Abbreviation: J Exp Clin Cancer Res Subsets: MEDLINE

MeSH-Schlagworte: Glioma*/genetics , Glioma*/cerebrospinal fluid , Glioma*/diagnosis , Brain Stem Neoplasms*/genetics , Brain Stem Neoplasms*/cerebrospinal fluid , Brain Stem Neoplasms*/diagnosis , Circulating Tumor DNA*/cerebrospinal fluid , Circulating Tumor DNA*/genetics , Mutation* , DNA Methylation* , Biomarkers, Tumor*/cerebrospinal fluid , Biomarkers, Tumor*/genetics, Humans ; Female ; Male ; Middle Aged ; Adult ; Prognosis ; Aged ; Young Adult ; Retrospective Studies

Circulating Tumor DNA (ctDNA) is Reliably Detected in Patients with Metastatic Malignant Phyllodes Tumors, a Feasibility Study.

Autoren: Reason EH Aiduk MD Nash AL et al.

Quelle: Annals of surgical oncology [Ann Surg Oncol] 2025 Oct; Vol. 32 (11), pp. 8299-8308. Date of Electronic Publication: 2025 Jul 23.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE

MeSH-Schlagworte: Circulating Tumor DNA*/blood , Circulating Tumor DNA*/genetics , Breast Neoplasms*/genetics , Breast Neoplasms*/pathology , Breast Neoplasms*/blood , Breast Neoplasms*/surgery , Phyllodes Tumor*/genetics , Phyllodes Tumor*/blood , Phyllodes Tumor*/secondary , Phyllodes Tumor*/surgery , Phyllodes Tumor*/pathology , Biomarkers, Tumor*/genetics , Biomarkers, Tumor*/blood , Neoplasm Recurrence, Local*/genetics , Neoplasm Recurrence, Local*/blood , Neoplasm Recurrence, Local*/pathology, Humans ; Female ; Middle Aged ; Feasibility Studies ; Prospective Studies ; Adult ; Prognosis ; Follow-Up Studies ; Exome Sequencing ; Mutation ; Survival Rate

Comprehensive genetic profiling using tissue and blood in locally advanced tumors.

Autoren: Fujiyoshi K Sugihara R Miyamoto N et al.

Quelle: Oncology reports [Oncol Rep] 2025 Oct; Vol. 54 (4). Date of Electronic Publication: 2025 Aug 08.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: D.A. Spandidos Country of Publication: Greece NLM ID: 9422756 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1791-2431 (Electronic) Linking ISSN: 1021335X NLM ISO Abbreviation: Oncol Rep Subsets: MEDLINE

MeSH-Schlagworte: Circulating Tumor DNA*/blood , Circulating Tumor DNA*/genetics , Biomarkers, Tumor*/genetics , Biomarkers, Tumor*/blood , Neoplasm Recurrence, Local*/genetics , Neoplasm Recurrence, Local*/blood , Neoplasm Recurrence, Local*/pathology , Neoplasms*/genetics , Neoplasms*/blood , Neoplasms*/pathology, Humans ; Female ; Male ; Middle Aged ; Pilot Projects ; Aged ; Gene Expression Profiling/methods ; Lung Neoplasms/genetics ; Lung Neoplasms/blood ; Lung Neoplasms/pathology ; Pancreatic Neoplasms/genetics ; Pancreatic Neoplasms/blood ; Pancreatic Neoplasms/pathology ; Adult ; Mutation

Quantitative and Dynamic ctDNA as a Biomarker of Response and Survival in Patients With Advanced Lung Squamous Cell Carcinoma Receiving Immunochemotherapy or Chemotherapy Alone.

Autoren: Zhou F Zhang J Ren S et al.

Quelle: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2025 Oct; Vol. 20 (10), pp. 1475-1488. Date of Electronic Publication: 2025 Jun 03.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Elsevier Country of Publication: United States NLM ID: 101274235 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1556-1380 (Electronic) Linking ISSN: 15560864 NLM ISO Abbreviation: J Thorac Oncol Subsets: MEDLINE

MeSH-Schlagworte: Lung Neoplasms*/drug therapy , Lung Neoplasms*/pathology , Lung Neoplasms*/genetics , Lung Neoplasms*/mortality , Lung Neoplasms*/blood , Circulating Tumor DNA*/genetics , Circulating Tumor DNA*/blood , Carcinoma, Squamous Cell*/drug therapy , Carcinoma, Squamous Cell*/genetics , Carcinoma, Squamous Cell*/pathology , Carcinoma, Squamous Cell*/mortality , Carcinoma, Squamous Cell*/blood , Biomarkers, Tumor*/genetics , Biomarkers, Tumor*/blood , Immunotherapy*/methods , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use, Humans ; Male ; Female ; Middle Aged ; Aged ; Survival Rate ; Prognosis